Tuberculin test reactivity in household contacts of tuberculosis patients from Huanuco, Peru;Reactividad de la prueba de tuberculina en contactos intradomiciliarios de pacientes con tuberculosis en Huánuco, Perú

Revista Peruana de Medicina Experimental y Salud Publica

Volumn 26, Issue 4, 2009, Pages 449-454

  Dámaso, Bernardo ^a,b   Díaz, Ramiro ^a,b   Menacho, Luz ^b   Loza, César ^c  

^a UNIVERSIDAD NACIONAL HERMILIO VALDIZÁN   (Peru)

^b Hospital Base II EsSalud de Huánuco   (Peru)

^c UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Latent tuberculosis; Peru (Source: MeSH NLM); Risk groups; Tuberculin test; Tuberculosis

Indexed keywords

EID: 77149177381     PISSN: 17264634     EISSN: 17264634     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bonilla C. Situación de la tuberculosis en el Perú. Acta Med Peru. 2008; 25(3): 163-70.
2. World Health Organization. Global tuberculosis control 2009: Epidemiology, strategy, and financing. Geneva: WHO; 2009.
3. Perú, Ministerio de Salud. Actualización de la norma técnica de salud para el control de la tuberculosis 2006. Lima: MINSA/DGSP; 2006.
4. Horsburgh C. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004; 350(20): 2060-67.
5. Barton L. Treatment of latent tuberculosis infection. N Engl J Med. 2003; 348(13): 1292-93.
6. Jasmer RM, Nahid P, Hopewell PC. Latent tuberculosis infection. N Engl J Med. 2002; 347(23): 1860-66.
7. Small P, Fujiwara P. Management of tuberculosis in the United States. N Engl J Med. 2001; 345(3): 189-200.
8. Liu Y, Weinberg M, Ortega L, Painter J, Maloney S. Overseas screening for tuberculosis in U.S.-Bound immigrants and refugees. N Engl J Med. 2009; 360(23): 2406-15.
9. Sterling T, Haas D. Transmission of Mycobacterium tuberculosis from health care workers. N Engl J Med. 2006; 355(2): 118-21.
10. Dirección Regional de Salud. Análisis de la situación de salud del departamento de Huánuco. Huánuco: DIRESA Huánuco; 2007.
11. Perú, Ministerio de Salud. Indicadores Básicos de Salud 2007: Indicadores de Morbilidad. Lima: DGE/MINSA; 2008.
12. Ministry of Health. Guidelines for tuberculosis control in New Zealand 2003. Wellington: Ministry of Health; 2002.
13. Leung C, Yew W, Tam C, Chan C, Chang K, Law W, et al. Tuberculin response in BCG vaccinated schoolchildren and the estimation of annual risk of infection in Hong Kong. Thorax. 2005; 60(2): 124-29.
14. Dahle U, Nordtvedt S, Winje B, Mannsaaker T, Heldal E, Sandven P, et al. Tuberculosis in contacts need not indicate disease transmission. Thorax. 2005; 60(2): 136-37.
15. Sanghavi D, Gilman R, Lescano-Guevara A, Checkley W, Cabrera L, Cardenas V. Hyperendemic pulmonary Tuberculosis in a Peruvian Shantytown. Am J Epidemiol. 1998; 148(4): 384-89.
16. Dasgupta K, Schwartzman K, Marchand R, Tennenbaum T, Brassard P, Menzies D. Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreignborn populations. Am J Respir Crit Care Med. 2000; 162(6): 2079-86.
17. Alsedà M, Godoy P. Factores asociados a la infección tuberculosa latente en los contactos de pacientes afectados. Gac Sanit. 2004; 18(2): 101-7.
18. Pilsczek F and Kaufmann S. Prevalence and predictors of positive tuberculin skin test results in a research laboratory. Rev Soc Bras Med Trop. 2008; 41(4): 416-18.
19. Brana C, Gómez J, Cayláb J, García P. Estudio de los factores asociados a la infección tuberculosa latente en inmigrantes menores de 35 años. Enferm Infecc Microbiol Clin. 2006; 24 (5): 322-25.
20. Laniado-Laborín R, Cabrales-Vargas N, López-Espinoza G, Lepe-Zúñiga JL, Quiñonez-Moreno S, Rico-Vargas CE. Prevalencia de infección tuberculosa en escolares de la ciudad de Tijuana, México. Salud Publica Mex. 1998; 40(1): 47-52.
21. Guwatudde D, Nakakeeto M, Jones-Lopez E, Maganda A, Chiunda A, Mugerwa R, et. al. Tuberculosis in household contacts of infectious cases in Kampala, Uganda. Am J Epidemiol. 2003; 158(9): 887-98
22. Lienhardt C, Sillah J, Fielding K, Donkor S, Manneh K, Warndorff D, et. al. Risk factors for tuberculosis infection in children in contact with infectious tuberculosis cases in the Gambia, West Africa. Pediatrics. 2003; 111(5): e608-e614.
23. Alarcón E. Riesgo anual de infección tuberculosa. Lima: Ministerio de Salud; 2004.
24. Bonifacio N, Saito M, Gillman R, Leung F, Córdova-Chavez N, Chacaltana-Huarcaya J, et al. High risk for tuberculosis in hospital physicians, Peru. Emerg Infect Dis. 2002; 8(7): 747-48.
25. Ziv E, Daley C, Blower S. Early therapy for latent tuberculosis infection. Am J Epidemiol. 2001; 153(4): 381-85.
26. Centers for Disease Control and Prevention. Guidelines for the investigation of contacts of persons with infectious tuberculosis recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep. 2005; 54 (RR-15):1-47.
27. Stop TB Partnership, World Health Organization. Global plan to stop TB 2006-2015. Geneva: WHO; 2006.
28. Teruel F, Castilla J, Hueto J. Abordaje de la tuberculosis en atención primaria. Estudio de contactos. An Sist Sanit Navar. 2007; 30(Supl. 2): 87-98.
29. Bailey W, Gerald L, Kimerling M, Redden D, Brook N, Bruce F, et al. Predictive model to identify positive tuberculosis skin test results during contact investigations. JAMA. 2002; 287(8): 996-1002.
30. Gómez F, Bernal J, García A. Evaluación y tratamiento de la tuberculosis latente en el adulto. Med Clin (Barc). 2001; 117(3): 111-14.